Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $53.2 million.

  • Organogenesis Holdings' Cost of Revenue rose 1064.71% to $53.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.7 million, marking a year-over-year decrease of 4326.83%. This contributed to the annual value of $115.7 million for FY2024, which is 869.64% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Cost of Revenue of $53.2 million as of Q3 2025, which was up 1064.71% from $48.9 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Cost of Revenue high stood at $53.5 million for Q2 2024, and its period low was -$36.2 million during Q4 2024.
  • For the 5-year period, Organogenesis Holdings' Cost of Revenue averaged around $28.7 million, with its median value being $26.7 million (2022).
  • Within the past 5 years, the most significant YoY rise in Organogenesis Holdings' Cost of Revenue was 10348.46% (2024), while the steepest drop was 23028.2% (2024).
  • Organogenesis Holdings' Cost of Revenue (Quarter) stood at $32.6 million in 2021, then decreased by 16.83% to $27.1 million in 2022, then increased by 2.43% to $27.8 million in 2023, then tumbled by 230.28% to -$36.2 million in 2024, then skyrocketed by 247.07% to $53.2 million in 2025.
  • Its Cost of Revenue was $53.2 million in Q3 2025, compared to $48.9 million in Q2 2025 and $23.7 million in Q1 2025.